News Sentiment

ANAB sentiment intelligence

AnaptysBio Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 66.39 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+4.7% over one week, +18.4% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

AnaptysBio (NASDAQ:ANAB) Trading 5.3% Higher - Should You Buy?

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 4.7% Price confirming higher
Trend fit Trend active 18.4% over four weeks
Fair value 205.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 34
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 17
TradingView 9
Stock Titan 6
MarketBeat 4
simplywall.st 4
Sahm 2
Investing.com Nigeria 2
Simply Wall Street 2

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 14
Analyst action 8
Balance sheet 1
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
TradingView Direct company coverage

AnaptysBio, Inc. Actuals & Estimates (NASDAQ:ANAB)

This article provides an overview of AnaptysBio, Inc. (ANAB) stock, including its current price, historical performance, analyst forecasts, and financial data. It highlights the stock's recent increase of 5.81% in 24 hours and a 303.32% increase over the last year, with analysts

Tone
Positive 71/100
Event
Analyst action
Published
26 Jun 2026 07:39
Source
TradingView
TradingView Direct company coverage

AnaptysBio, Inc. Actuals & Estimates (BIVA:ANAB)

This article provides financial actuals and estimates for AnaptysBio, Inc. (ANAB) on the BIVA exchange, including analyst price targets, market capitalization, volatility, and historical earnings performance. It also details upcoming earnings dates and revenue projections, along

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 07:10
Source
TradingView
Stock Titan Direct company coverage

AnaptysBio (NASDAQ: ANAB) subleases San Diego facility to First Tracks under master lease

AnaptysBio, Inc. has subleased 45,057 rentable square feet of its San Diego facility at 10770 Wateridge Circle to First Tracks Biotherapeutics. This sublease, which began on June 15, 2026, runs for 12 months with an option for First Tracks to extend until April 4, 2028, or for an

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 04:41
Source
Stock Titan